Polyamines in frontal cortex of patients with Down syndrome and Alzheimer disease.
Polyamines may play an important role in brain development, mature brain function and also in neurodegenerative conditions. We investigated polyamine levels in frontal cortex of human post-mortem brain samples of elderly patients with Down syndrome (DS), Alzheimer disease (AD) and normal controls by means of chromatographic separation after dansylation. Spermidine and spermine concentrations were markedly decreased in DS and AD. Polyamine levels were neither related to age and post-mortem interval nor to choline acetyltransferase activity, as indicator of neuronal loss. Our results support the idea that besides other neurotransmitter systems, endogenous polyamine levels are altered in dementing illnesses such as Alzheimer disease and Down syndrome.
Seidl
R
R
Department of Paediatrics, University of Vienna, Austria.
Beninati
S
S
Cairns
N
N
Singewald
N
N
Risser
D
D
Bavan
H
H
Nemethova
M
M
Lubec
G
G
D000368:Aged; D000544:Alzheimer Disease / Q000378:metabolism*; D016022:Case-Control Studies; D002795:Choline O-Acetyltransferase / Q000378:metabolism; D004314:Down Syndrome / Q000378:metabolism*; D005260:Female; D005625:Frontal Lobe / Q000378:metabolism*; D006801:Humans; D008297:Male; D008875:Middle Aged; D013095:Spermidine / Q000378:metabolism*; D013096:Spermine / Q000378:metabolism*
D013096:Spermine; D002795:Choline O-Acetyltransferase; D013095:Spermidine